Literature DB >> 22865238

Expanded and independent validation of the Movement Disorder Society-Unified Parkinson's Disease Rating Scale (MDS-UPDRS).

Pablo Martinez-Martin1, Carmen Rodriguez-Blazquez, Mario Alvarez-Sanchez, Tomoko Arakaki, Alberto Bergareche-Yarza, Anabel Chade, Nelida Garretto, Oscar Gershanik, Monica M Kurtis, Juan Carlos Martinez-Castrillo, Amelia Mendoza-Rodriguez, Henry P Moore, Mayela Rodriguez-Violante, Carlos Singer, Barbara C Tilley, Jing Huang, Glenn T Stebbins, Christopher G Goetz.   

Abstract

The Movement Disorder Society-UPDRS (MDS-UPDRS) was published in 2008, showing satisfactory clinimetric results and has been proposed as the official benchmark scale for Parkinson's disease. The present study, based on the official MDS-UPDRS Spanish version, performed the first independent testing of the scale and adds information on its clinimetric properties. The cross-culturally adapted MDS-UPDRS Spanish version showed a comparative fit index ≥ 0.90 for each part (I-IV) relative to the English-language version and was accepted as the Official MDS-UPDRS Spanish version. Data from this scale, applied with other assessments to Spanish-speaking Parkinson's disease patients in five countries, were analyzed for an independent and complementary clinimetric evaluation. In total, 435 patients were included. Missing data were negligible and moderate floor effect (30 %) was found for Part IV. Cronbach's α index ranged between 0.79 and 0.93 and only five items did not reach the 0.30 threshold value of item-total correlation. Test-retest reliability was adequate with only two sub-scores of the item 3.17, Rest tremor amplitude, reaching κ values lower than 0.60. The intraclass correlation coefficient was higher than 0.85 for the total score of each part. Correlation of the MDS-UPDRS parts with other measures for related constructs was high (≥ 0.60) and the standard error of measurement lower than one-third baseline standard deviation for all subscales. Results confirm those of the original study and add information on scale reliability, construct validity, and precision. The MDS-UPDRS Spanish version shows satisfactory clinimetric characteristics.

Entities:  

Mesh:

Year:  2012        PMID: 22865238     DOI: 10.1007/s00415-012-6624-1

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  32 in total

1.  Movement Disorder Society Task Force report on the Hoehn and Yahr staging scale: status and recommendations.

Authors:  Christopher G Goetz; Werner Poewe; Olivier Rascol; Cristina Sampaio; Glenn T Stebbins; Carl Counsell; Nir Giladi; Robert G Holloway; Charity G Moore; Gregor K Wenning; Melvin D Yahr; Lisa Seidl
Journal:  Mov Disord       Date:  2004-09       Impact factor: 10.338

2.  The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study.

Authors:  Kallol Ray Chaudhuri; Pablo Martinez-Martin; Richard G Brown; Kapil Sethi; Fabrizio Stocchi; Per Odin; William Ondo; Kazuo Abe; Graeme Macphee; Doug Macmahon; Paolo Barone; Martin Rabey; Alison Forbes; Kieran Breen; Susanne Tluk; Yogini Naidu; Warren Olanow; Adrian J Williams; Sue Thomas; David Rye; Yoshio Tsuboi; Annette Hand; Anthony H V Schapira
Journal:  Mov Disord       Date:  2007-10-15       Impact factor: 10.338

3.  Validation of the MDS-UPDRS Part I for nonmotor symptoms in Parkinson's disease.

Authors:  David A Gallagher; Christopher G Goetz; Glenn Stebbins; Andrew J Lees; Anette Schrag
Journal:  Mov Disord       Date:  2011-09-13       Impact factor: 10.338

Review 4.  Psychometric considerations in evaluating health-related quality of life measures.

Authors:  R D Hays; R Anderson; D Revicki
Journal:  Qual Life Res       Date:  1993-12       Impact factor: 4.147

5.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 6.  The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease.

Authors:  W R Gibb; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-06       Impact factor: 10.154

7.  International study on the psychometric attributes of the non-motor symptoms scale in Parkinson disease.

Authors:  P Martinez-Martin; C Rodriguez-Blazquez; K Abe; K B Bhattacharyya; B R Bloem; F J Carod-Artal; R Prakash; R A J Esselink; C Falup-Pecurariu; M Gallardo; P Mir; Y Naidu; A Nicoletti; K Sethi; Y Tsuboi; J J van Hilten; M Visser; M Zappia; K R Chaudhuri
Journal:  Neurology       Date:  2009-11-10       Impact factor: 9.910

8.  A short scale for the assessment of motor impairments and disabilities in Parkinson's disease: the SPES/SCOPA.

Authors:  J Marinus; M Visser; A M Stiggelbout; J Martin Rabey; P Martínez-Martín; U Bonuccelli; P H Kraus; J J van Hilten
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

9.  Standard error of measurement as a valid alternative to minimally important difference for evaluating the magnitude of changes in patient-reported outcomes measures.

Authors:  Javier Rejas; Antonio Pardo; Miguel Angel Ruiz
Journal:  J Clin Epidemiol       Date:  2007-10-15       Impact factor: 6.437

10.  Test-retest reliability of the unified Parkinson's disease rating scale in patients with early Parkinson's disease: results from a multicenter clinical trial.

Authors:  Andrew Siderowf; Michael McDermott; Karl Kieburtz; Karen Blindauer; Sandra Plumb; Ira Shoulson
Journal:  Mov Disord       Date:  2002-07       Impact factor: 10.338

View more
  53 in total

1.  Handling missing values in the MDS-UPDRS.

Authors:  Christopher G Goetz; Sheng Luo; Lu Wang; Barbara C Tilley; Nancy R LaPelle; Glenn T Stebbins
Journal:  Mov Disord       Date:  2015-02-04       Impact factor: 10.338

2.  Validation of the multimodal assessment of capacities in severe dementia: a novel cognitive and functional scale for use in severe dementia.

Authors:  Sloane Heller; Carolina Mendoza Rebolledo; Carmen Rodríguez Blázquez; Laura Carrasco Chillón; Almudena Pérez Muñoz; Irene Rodríguez Pérez; Pablo Martínez-Martín
Journal:  J Neurol       Date:  2015-03-06       Impact factor: 4.849

3.  Detection, Assessment, and Management of Schizophrenia in an Andean Population of South America: Parkinsonism Testing and Transcranial Ultrasound as Preventive Tools.

Authors:  Mara Balda; Maria Calvó; Eduardo Padilla; Gonzalo Guerrero; Juan Molina; Nestor V Florenzano; Danielle Kamis; Javier I Escobar; C Robert Cloninger; Gabriel de Erausquin
Journal:  Focus (Am Psychiatr Publ)       Date:  2015

4.  Cross-Cultural Differences of the Non-Motor Symptoms Studied by the Traditional Chinese Version of the International Parkinson and Movement Disorder Society- Unified Parkinson's Disease Rating Scale.

Authors:  Rwei-Ling Yu; Ruey-Meei Wu; Anne Y Y Chan; Vincent Mok; Yih-Ru Wu; Barbara C Tilley; Sheng Luo; Lu Wang; Nancy R LaPelle; Glenn T Stebbins; Christopher G Goetz
Journal:  Mov Disord Clin Pract       Date:  2016-04-08

5.  Independent Spanish Validation of the Unified Dyskinesia Rating Scale.

Authors:  Esther Cubo; Christopher G Goetz; Glenn T Stebbins; Nancy R LaPelle; Barbara C Tilley; Lu Wang; Sheng Luo
Journal:  Mov Disord Clin Pract       Date:  2014-08-05

6.  Commonalities and challenges in the development of clinical trial measures in neurology.

Authors:  Jesse M Cedarbaum; Diane Stephenson; Richard Rudick; Maria C Carrillo; Glenn Stebbins; Douglas Kerr; Jill Heemskerk; Wendy R Galpern; Petra Kaufmann; David Cella; Maria Isaac; Marc K Walton
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

7.  Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease.

Authors:  Jared T Hinkle; Kate Perepezko; Kelly A Mills; Zoltan Mari; Ankur Butala; Ted M Dawson; Alexander Pantelyat; Liana S Rosenthal; Gregory M Pontone
Journal:  Parkinsonism Relat Disord       Date:  2018-08-22       Impact factor: 4.891

Review 8.  Instruments for holistic assessment of Parkinson's disease.

Authors:  Pablo Martinez-Martin
Journal:  J Neural Transm (Vienna)       Date:  2013-03-10       Impact factor: 3.575

9.  Apathy and associated factors in Mexican patients with Parkinson's disease.

Authors:  Mayela Rodríguez-Violante; Paulina González-Latapi; Amin Cervantes-Arriaga; Daniel Martínez-Ramírez; Salvador Velázquez-Osuna; Azyadeh Camacho-Ordoñez
Journal:  Neurol Sci       Date:  2013-12-05       Impact factor: 3.307

10.  Psychometric properties of the Berg balance scale in idiopathic Parkinson' disease in the drug off-phase.

Authors:  Ghorban Taghizadeh; Pablo Martinez-Martin; Seyed-Mohammad Fereshtehnejad; Seyed Amirhasan Habibi; Negar Nikbakht; Naeeme Haji Alizadeh; Sheyda Salehi; Maryam Mehdizadeh
Journal:  Neurol Sci       Date:  2018-09-22       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.